Reddit Posts
T2 Biosystems (TTOO) vs. IDEXX Laboratories (IDXX): Which medical stock is set to outperform in October?
Sold my ATVI stock and bought CMG, CROX, LYV, and NVIDIA
What are your thoughts on my price targets for: ATVI, EA, IDXX, ROKU, TTWO, and ZTS
What would you do with a stock you own trading at a high valuation, but you're a long-term investor and don't have a better idea?
🦋 Butterfly Network Emerging from its Cocoon $BFLY DD 🦋
($2.35) ZOM Chapter II - Get in before ZOM goes BRRRRRRR 🚀🚀🚀
Mentions
IDXX being green all this time besides being grossly undervalued while the market gets destroyed suddenly makes sense.
IDXX are shit, overvalued and they have managed to remain green by sidetrading the same shit 22 shares order over and over, who is rigging that, pisses me off
I am very confused here, why is IDXX allowed to day-trade the same 22 shares to pump their valuation when they are about 70 PE and intrinsic valuation is in the $400? Are Market Makers ignoring this, I would think this is what MMs punish with their liquidity, so what's up with this blatant penny-stock style of pump and dump?
IDXX still green due to the 3 investors holding a line with 3 shares lol, get the popcorn, it already start to sell off. I want to see this shitshow.
Literally only 2 buy shares holding IDXX "green day" so it does not fall through a sea of blood during market hours, you cannot make this shit up, that EMA floor is broken bags when their CEOs dumped at peak 5 days ago... yikes.
IDXX is "green" because hopeful bag holders are microtrading 24 shares per hour and hoping no one finds out they are pumping that low volume scam, CEOs literally dumped at the top after a 2x YTD gain, lmao. They will get so fucked
I kept looking at it to the close yesterday especially after seeing IDXX rocket. Didn't buy, cheering from the side lines :^)
Will my IDXX puts print lmao
Am i regarded for getting IDXX puts
Anyone thinking puts on IDXX after that 140 bucks pump
IDXX went up 25% today. one of the options went up 108K%
Interesting. Key Observations: - The majority of congressional trades in IDXX have been purchases, with only a single recent sale. - Several purchases are clustered in early April 2025, some involving relatively larger amounts. - Trading activity is from members with unknown party affiliation in the reporting data. [Source](https://youtube.com/shorts/rq2CbFj9Sg0?si=-PDgm6Dk5k3ecG3w)
Did you buy the stock the day it was introduced? If not, then you have no grudge here. If you did then sure complain Delaney got a few extra percent. If you didn't then just accept the fact you missed it and try to pay better attention. You have to pay attention to make money in the stock market. This is something that really annoys me. The information was there for anyone to read. All you had to do was pay attention. You didn't. So you didn't make money. Most of Congress didn't pay attention either, now did they? A lot of other people bought $IDXX on the day of the news. So a lot of people figured this out. Just not you, or the OP, or the other members of Congress. And, that won't change unless you start paying attention.
[https://bidenwhitehouse.archives.gov/briefing-room/presidential-actions/2022/09/12/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/](https://bidenwhitehouse.archives.gov/briefing-room/presidential-actions/2022/09/12/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/) This has been in the works since 2022. You could have bought the stock the same day the Bill was filed to the Senate. You could have bought $IDXX the same day the Delaney did. The Delaney figured out what to buy is not a reason to be upset. You had the same information at the same time and you didn't figure it out. Pay attention next time.
One company that consistently grows and where DCA makes sense would be Visa (V). Another gem with an extremely long runway for growth could be Idexx Laboratories (IDXX). Finally - if you look for something very tangible and physical with low disruption risk - almost always overvalued but with DCA it evens out - Waste management (WM).
Good question! Here’s mine: • HESAY (Hermès): Known for its luxury goods like Birkin and Kelly bags, Hermès has a strong brand and consistent revenue growth, making it a solid long-term investment. • MELI (MercadoLibre, Inc.): As the leading e-commerce platform in Latin America, MercadoLibre benefits from the region’s growing internet penetration and e-commerce adoption. • IDXX (IDEXX Laboratories, Inc.): Specializing in veterinary diagnostics, IDEXX is positioned well in the growing pet care industry with innovative products and services. • MSCI (MSCI Inc.): A leader in global indices and analytics, MSCI benefits from increasing demand for data-driven investment strategies. • MA (Mastercard Incorporated): With its extensive global payment network, Mastercard is poised to capitalize on the shift towards digital payments
Yes, ditch the bonds until you are over 40. Some stocks I like at: current prices MELI IDXX ASML But, I’d focus on the ETFs first!
Thanks, very good inputs and questions! 1) EW has re-rated because of a temporary slow down in growth but it is fundamentally a great and profitable company (last 20 + years with stable and high ROIC) and I count on long term secular growth to pick up again from 2026. The huge dip in EW share price was partly because of an overreaction (fear of obesity medicine willl cure heart desease, but I think the opposite will happen - more people will be able to actually get treatment when they loose weight). 2) ZTS / IDXX: I have held ZTS for a long time and it is a stable core position. IDXX is a recent addition. It has only traded at these multiples very few times since 2017. It has a solid marked position, so I figured it to be a good time to diversify instead of keep adding to ZTS. Both ZTS and IDXX are fundamentally well run businesses with stable/rising margins and I think they are both still here 20 years from now. 3) PAYC (along with BILL) was my play on "small-cap". Instead of trying to find a basket of US-small-cap, why not invest on those who will benefit from small-cap taking off? Both have played out almost perfectly in 2024 but even after huge gains, are still trading at reasonable price compared to expected growth. I have worked with HR-software and know exactly how hard it is to switch and I think the PAYC strategy of providing wall-to-wall for smaller companies, has benefits compared to the other vendors in the space (it is tempting for smaller business who have a hard time finding ressources to manage their integrations, but once they are on board, the lock-in is stronger). 4) Good call! I have my eyes on TMO as well - waiting for a price in the 16-18 EV/EBITDA range and may have a critical look at A to find the money. 5) Waiting to see what ABNB will do with their huge war chest ;-)
I don't think this is bad, but: 1) what is your thesis for an EW turnaround? 2) while I know they're not apples-to-apples, I'd say consider choosing ZTS or IDXX and concentrating in one or the other 3) it's bounced lately, but what's the medium/long-term thesis for PAYC? 4) would rather TMO or RGEN than A but it's not a bad company 5) would actually rather diversified BKNG than ABNB.
I can't imagine ever selling: MCO, SPGI, CNI, CP, CPRT, IDXX, RY
I see, so there is no particualr reason why chose to get exposure here through ZTS instead of IDXX ?
Yeah, that’s basically why it’s third place. It started out as a smaller holding but has done really well for itself. It’s also kind of an example of *One up on Wall Street*-inspired “buy what you know” thinking. This and Idexx Labs (IDXX) are companies I only really know about because of my pets.
Just curious, what other 15 stocks? I'm an IDXX stockholder as well. Was thinking about RMD, it looks interesting but like you said one trick pony
$32K move into VOO or VTSAX yes/no? I have a pretty scattered portfolio (70+ positions) and am considering doing a bit of consolidation on a handful of stocks largely purchased in the last 3-4 years into either VOO or VTSAX. Total dump would be around $32k. I already have a decent chunk of VOO (!$17k +160%) which has performed pretty well and doesn’t keep me up at night. Am I crazy for doing this? Anything you’d personally hold onto here? Long term investor, so no immediate need/concern and can ride things out over fluctuations. Stock - Performance - Year purchased GMED +16% 2020 IDXX + 7% 2021 NBIX + 19% 2020 OXY + 330% 2020 TDC - (31%) 2013 TYL + 10% 2022
I would simply long IDXX.
Netflix - $544 Microsoft - $398 AMD -$168 Roku - $90 Taiwan semiconductor- $114 Constellation software - $3658cad Adobe - $597 Qualcom - $153 Shopify - $81 Nvidia - $598 Costco - $687 Lululemon- $477 Spotify - $206 Tesla - $209 Intel - $48 Apple - 195$ Amazon - $156 Meta platform- $385 Micron technology- $87 Oracle corp - $111 Sea limited - $38 Zoom communication- $69.63 T-mobile - $163 IBM - $173 Crowdstrike - $297 Cloudflare - $83 Palo alto networks - $344 Sales force - $276 Snowflake - $205 Broadcom - $1226 Accenture - $369 Thermo fisher scientific - $550 Service now - $753 Intuitive surgical - $371 Lam research corp - $830 Automatic data processing - $240 Analog devices - $201 Mercadolibre - $1759 Workday - $291 IDXX - $531 Take two interactive software - $165 Regal rex coorperation - $89(aerospace) The boeing company - $211 Inhibrx - $36 Cisco systems - $51 Super micro computer - $457 ASML holdings - $846
MSTR, PLTR, AMZN, COIN MSTR and COIN have already had great runs this year, the btc bottom is certainly in and 2024 will be huge for btc and that tech in general, Coin will have exponential gains as the chosen custodian for blackrock and with the uncertainty around binance. PLTR continue to make huge government contracts, they are quietly developing their tech and improving profitability. AMZN is seriously undervalued compared to other major corps. They continue to grow revenue, profits and are so heavily invested in R&D. A couple of other really promising stocks for 2024: VEEV and IDXX : both fantastic healthcare stocks with great financials, very strong moats and undervalued over the past 2 years. They are ready to play catch up 2024-2025. They will also protect you longer term from any SPX downturn.
So, genuine question: what are you looking for? If you are worried about inflation then it becomes real assets and things that have traditionally maintained pricing power over time. Mega cap tech - which you mention in the original post - has done well but it is a crowded trade to say the least. IMO, tech should certainly be an element of a portfolio but there is a point with everyone and their cousin owning mega cap tech that people should make some moves towards understanding small/mid cap names and looking for at least one or two of what they strongly think are the next big things. There's a lot of fantastic businesses out there that have delivered for shareholders year in/year out over time - ODFL, CPRT - but they aren't cheap either. MCK - McKesson is one of the three large drug distribution cos and ships about a third of the drugs used every day in the US. Not cheap but an example of a large moat and some inflation protection over time: "Some of our distribution arrangements with manufacturers provide us consideration based on a percentage of our purchases. In addition, we have certain distribution arrangements with pharmaceutical manufacturers that include an inflation-based consideration component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices." IDXX and LVMUY are other examples; the latter is *somewhat* more reasonable after pulling back due to concerns over China and normalization of luxury spending after the last couple years. If you look at CPG names that are down a lot - MKC is a name that has done exceptionally well over time but not in recent years. They do at least have a moat with around 20% share of spices and with higher food costs, people can dress up meals with some reasonable spice mixes. I'm not a fan of piling into a lot of things that haven't worked within the last 5 years but that's an example of something that has been around for over 100 years and will work through things. EL is another. So, portion of the portfolio in aggressive growth (although I really would say not just mega cap tech and not just tech; some smaller/mid tech names and growth in other industries), portion of the portfolio iin high quality medium growth (although a lot of that is not cheap and consider waiting for a pullback) and maybe some selected slow growth/value and one or two high quality names that haven't worked and where there might be a turnaround.
These are not recommendations by me. But $IDXX and $ZTS are fairly popular pet medicine/research stocks. Do your own DD.
> but I am getting sick of the markets, something I once loved. > Felt similar in 2022 and to a somewhat lesser degree at times this year but for somewhat different reasons. IMO, it feels like the "moderate, multi-year growth story" (IDXX several years ago before pet health became a broader theme is an example I often use) is much more difficult. Now growth themes feel more limited and fairly narrow, everyone and their cousin moons it in months and then eventual rug pull. On the opposite end, anything thought as a loser impacted by said growth theme becomes a "no touch" - see medtech over the last 3 months. Companies with issues are obliterated, sold some more and then...nothing much as it almost feels like a buyers strike. There are certainly good, high quality names that still are not on the radar of many - u/creemeeseason has called out a number of them. There are certainly Coparts and other high quality names doing well, too but it really does feel more difficult to generate new ideas in this environment - at least imo. "Fact that the world defines the US Market right now in 7 companies is maddening" There are certainly other things doing really well too, but it really does feel like even what's doing well is in such a fragile state that one minor mispoken sentence on a conference call could send something to time out for months.
I've been owning ZTS & IDXX for multiple years. Both are top holdings in my portfolio.
Thank you for your reply. > Pet spending is not recession proof; you're seeing some decline wih Petco and you can look at the helpful infographics that IDXX provides with earnings in terms of vet visits. Pet spending may be recession-resistant, but people could spend less (less discretionary buys, food downgrades.) Maybe not recession proof, but still, getting a dog or a cat means over ten, often even over 15 years of locked in customers. They might spend less, but they will spend a lot of money over their lifespan. The lifespan will probably be even longer when they do spend that money. And I would expect that many who have a loving / family relationship with a dog, you will get another one not too long after that one dies. > LLY/NVO certainly have a compelling story with the obesity drugs (LLY is a huge holding for me), but I do think that a lot is priced in and there are still risks. Best case scenario over the long-term is certainly compelling (and I think somewhat game changing for some industries), but still very mindful of risks. WST/STVN have also been supply chain obesity drug beneficiaries. Yes, sure, but the financials are incredible even without the obesity drugs. I would say that the multiples will contract over time, but I expect that earnings growth will be stronger than the multiple contraction over decades. There is a lot of growth even with purely focusing on diabetes, which won't be the case. > EL I really think that EL will appreaciate a lot over the next 10 years, I expect this volatility to be temporary, and I think the most reasonable approach would be to not sell it (as I did), but I'm not sure I'd stomach the volatility, which is why I sold it. I lost about 19% on it. Both L'Oreal and Estee Lauder Cos have an incredible portfolio of brands that continues to evolve. But I'm more content with L'Oreal now. And I have enough exposure to the beauty market with ULTA, L'Oreal and LVMH (which owns Sephora, so I am exposed to over half of the retail along with ULTA). In a year or two, I might revisit EL and reevaluate.
I like your portfolio, like your thoughtful approach and enjoyed both this post as well as the prior one. Concerns are relatively minor. Pet spending is not recession proof; you're seeing some decline wih Petco and you can look at the helpful infographics that IDXX provides with earnings in terms of vet visits. Pet spending may be recession-resistant, but people could spend less (less discretionary buys, food downgrades.) LLY/NVO certainly have a compelling story with the obesity drugs (LLY is a huge holding for me), but I do think that a lot is priced in and there are still risks. Best case scenario over the long-term is certainly compelling (and I think somewhat game changing for some industries), but still very mindful of risks. WST/STVN have also been supply chain obesity drug beneficiaries. "I briefly held EL which I sold (at loss) and bought L'oreal instead." EL is another example like DIS/PYPL of a company with issues and it hits levels where people think "how much further could it go?" It then proceeds to answer that question by losing another 20%+. EL is absolutely long-term compelling IMO, but this continues to be a market where what is doing okay-ish is being sold to buy what's doing well and what is not working is being sold without a second thought and then sold some more. I don't like to speculate on deals, but LVMH has some expressed interest in EL in the past; on the *possibility* that were to occur, whether or not the family would want to sell is the question. L'Oreal is probably better managed and more consistent, but an EL turnaround... eventually is somewhat interesting.
I like your portfolio, like your thoughtful approach and enjoyed both this post as well as the prior one. Concerns are relatively minor. Pet spending is not recession proof; you're seeing some decline wih Petco and you can look at the helpful infographics that IDXX provides with earnings in terms of vet visits. Pet spending may be recession-resistant, but people could spend less (less discretionary buys, food downgrades.) LLY/NVO certainly have a compelling story with the obesity drugs (LLY is a huge holding for me), but I do think that a lot is priced in and there are still risks. Best case scenario over the long-term is certainly compelling (and I think somewhat game changing for some industries), but still very mindful of risks. WST/STVN have also been supply chain obesity drug beneficiaries.
Rather than just picking the same big tech stocks as everyone else, my choices would be: CARR - climate and energy policies, growing demand for heat pumps, larger installed base of houses for servicing and repairs, etc. CP - Mexico and Canada surpassed China as the US' largest trading partners in 2022 and I expect trade with Mexico will continue to grow with near-shoring efforts. DHR (or TMO) - picks and shovels play on pharma, biotech, etc. ZTS (or IDXX) - younger generations have more pets and spend more per pet V - digital payments continue growing and Visa provides the payment rails that everyone else uses to process transactions
I'm investing to FIRE in 10 years by 39. I'm also an active stock picker, not passive. Stocks I hold generally are not large caps although that was a bad decision on my part if you hold FAANG + Microsoft & Tesla already so ignore me. They need to be a market share leader, high barriers to entry in industry, a secular tailwind, and a long product lifecycle. This has led me to invest in animal healthcare (IDXX & ZTS), video games (ATVI, EA, TTWO), ROKU is my top holding, and small positions in CMG, LYV, and CROX. Stay diversified to avoid 1 stock dragging down your portfolio & FIRE goals. Right now ROKU is my #1 stock which good based on this year's price action but in a few years may trim and redeploy into CMG, LYV, and CROX. Also looking to sell EA to redeploy in better quality businesses. You may not like my stocks, but pick your own stocks, diversify, and do not pick boomer sticks and you should be able to FIRE in 10 years like I'm planning.
I don't know about the companies so not going to say either way about them specifically but a couple general thoughts: 1) I think TikTok and Youtube has made it too easy to pump penny stocks and selling these stories as get rich quick. Maybe there's a short squeeze but that's a hope at best and if you're owning companies that are not good companies on the hope of a short squeeze, they could also easily continue to head in the wrong direction as lack of fundamentals continue to weigh. It's gambling and maybe you luck out, maybe you don't but if the fundamentals aren't there eventually the stock is lower. I'd recommend limiting these sorts of investments to ones where you really feel very strongly and have a very solid thesis. 2) I think a lot of people especially some starting out are focused on home runs and try to swing for the fences with a lot of investments and you can strike out quickly trying to do that, especially in a difficult market. I think people should try to focus on consistently getting on base and if you can consistently get singles, doubles and the occasional triple. Sometimes you will see a home run pitch and you can really focus on that but it's not going to be all the time. Solid returns aren't going to be always be flashy stocks either - I don't own it anymore but I did very well when I bought IDXX at $100. I thought the theme of pet ownership would see more significant growth and a few years later, Cramer was talking up the "humanization of pets" theme. There were pet ETFs whereas there weren't any previously. What's a relatively boring name where people aren't appreciating its connection with whole or part of the business to a relevant theme?
$RIG ahead of the 22nd earnings (and as people take NASDAQ profits, AI on the ChatGPT hype, IDXX for the love of furballs ahead of even rent money, and RIOT as bitcoin pushes to break over the 24K mark
I'm in ZTS & IDXX. I like animal health more because it's faster growing & less riskier than human health.
The healthcare sector is usually a pretty good bet overall. I think it might be the best performing sector of the last 30 years. A couple others I've started buying over the past few months are IDXX and WST. I'm not really interested in buying tech stocks and prefer to look for quality companies with strong growth prospects in other industries. Semiconductors are the only tech play I have for my individual stocks.
What would you add to this: $MSFT $GOOGL $TMO $IDXX $LVMH $V $MA $SNOW $DDOG
In a broad sense, what I'm saying is that 2020 was a frenzy over anything that was considered "disruptive growth" and there was a mentality that all of these things were going to be winners, which I think was particularly emphasized by Cathie Wood and Ark. The reality was that that wasn't the case and two years later some of these businesses look like they're potential 0's. Not only were some of these businesses not going to be winners in the first place, but trends that took place during covid that many thought would continue clearly did not - even Zuckerberg talked about being wrong on this in the letter the other day. What is really a sustainable business model? If something is not a profitable business and has no line of sight to that tomorrow, that is going to face real difficulty in a time where money is no longer cheap and may not be cheap again for quite some time. It's quite possible that in the coming years, "exciting stories" aren't going to be enough and companies are going to have to show profits or point to a very quick path towards them. Unsustainable businesses in a time of cheap money have been able to continue a lot longer than they would have otherwise but if we're not going back to ultra low rates any time soon (and after the debacle of the last year that seems unlikely to happen anytime soon) then these businesses are going to have a very difficult time - and you've already seen it with a lot of names down 70-80-90% YTD. Additionally, you've seen considerable multiple compression that has come with rapidly rising rates. There are names that are very high quality businesses that have traded at very high multiples for years. Something like IDXX was halved. Great business, but with higher rates, a business that was always labeled "expensive" because of its quality - people are no longer willing to pay up in the same way in an environment of much higher rates. So while most of the obliteration has occurred in expensive growth, even expensive high quality wasn't spared in a number of cases. So imo what do the next few years look like, in sort of best case possibilities? 1. We bounce back eventually, the Fed pivots, rates go back down, maybe a more significant recession but eventually that passes. Growth party back on. Given the impressive eagerness to stampede back into aggressive growth in the last couple of days, this is what people **CLEARLY** seem to want (and I certainly wouldn't complain), but I have very little belief that it occurs. 2. We gradually recover but rates remain higher for longer. The recovery feels more like 2002-2008 post dot com bust than 2009-2021 post financial crisis. The market trades at cheaper multiples. Tech recovers as it did post dot com but is not the leadership that it was in 2009-2021 and growth names recover but not to the degree some would like because the 2020 valuations are not going to be seen again for many years in this new environment. A more gradual recovery is not going to be enough for some unsustainable businesses and while there will be big bounces, some 2020 names are still eventual 0's. The market is more realistic/reasonable and while some things will do well/very well, it is overall less exciting/less "story driven" than the last decade and will require a lot more stockpicking/different playbook rather than just "rising tide lifts all growth boats." I'd like #1, but given what has occurred in the last year, #2 feels like a more likely way that the next few years may play out in a best case. Worst case scenario is the Elliott Management letter from a week or two ago, which is 28 pages of some considerable doom. And Elliott has had what, 2 losing years since 1977?
Solid list. IDXX might be another good one to keep an eye on. ZTS too.
This company doesn't have a shot. IDXX has an iron grip on the animal diagnostics industry.
ADBE a buy for a couple shares down over 50% this year? Also IDXX same situation?
The problem becomes if stocks are at high valuations and you have significant fed tightening, you're going to have multiple compression. Look at something like IDXX; you have a great business that was consistently richly valued. -50% in the last 15 mo or so. It's still a great business, still doing reasonably well considering the economic environment - but you have had considerable multiple compression.
IDXX & ZTS: People have had pets since the beginning of time and in the past few decades people have been treating their pets like family and have access to better Healthcare which will set up spending to be resilient for a long-time Live Nation: People have enjoyed listening to music, watching sports, and attending live shows since the beginning of time. The type of entertainment has changed from gladiator fights in Amcient Greece to NFL football, rock, rap, and country music. Regardless of those taste changes, chances are LYV will be the one selling the tickets and organizing the show ROKU: I think watching cable will go away and people are going to stream TV Warner Bros Discovery: People like to be entertained and they make good content that pleases a lot of people.
Mostly buy and hold. Biggest hits Nike, TXN,AAPL,IDXX. Key too, my wife makes bank and is thrifty.
Look for trends in society where you think the market is underestimating sustainable/significant growth. People think these trends always = slick tech company but definitely not always the case. I bought IDXX at 100 in 2016 on a view towards a ramp in pet ownership/pet spending and a few years later Cramer was going on about the "humanization of pets" theme. Don't own it now but did very well.
I only had IDXX this morning and the earnings made me sad lol. This environment is really hitting them hard.
I own three video game stocks (ATVI, EA, & TTWO), two animal health stocks (IDXX & ZTS), and ROKU. My strategy in this bear market is to dollar cost average in my companies. I'm not expecting to make money in the short-term, but I'm hoping my companies keep executing their roadmap against the competition during the recession and when the economy improves their share prices will go back up and they'll be stronger relative to the competition. I'll be focusing my investments on ROKU & TTWO.
What you think of IDXX these days?
I don't like any of your picks because you chose the largest companies today and they can be overthrown by disruption. For example, Microsoft, Cisco, Exxon Mobil, GE, and Intel were the top 5 stocks 20 years ago and the thesis on each stock has changed significantly. I would pick stocks that can't really be disrupted as evidenced by the proof of time & the investment thesis never changes. For example, People will always love their pets and want to take care of them. So hold ZTS & IDXX. People will always love music & seeing their favorite artist in person so buy LYV.
Idexx Laboratories (IDXX). It's the main producer of medical equipment for pets.
For me, in late 2018 and March 2020 (particularly the latter), I was dialing up aggressive growth stocks. Now? There's been a little nibbling at best and the shopping list looks somewhat different this time around. Looking for "next big thing" growth stories has gone from high on the list to the bottom. I've nibbled on some more established growth companies that are down substantially. DXCM went down about 30% in a month, then tanked further because of concern over a rumor that they were going to buy another company. I own a little bit of IDXX again after not owning it for some time. Added to DHR. Established, profitable growth names with a long track record and businesses (particularly more "need based") that I can feel comfortable owning are things that I'd look to nibble on. I've added back a couple of real estate names that are now down pretty significantly off highs. Little by little, I've made some more room for real assets. I've added more to alternative strategies and given the way things are going and how they've done through now two unprecedented periods, those will probably stick around for a while. So have I been buying? Yes, but specific, higher quality/less speculative names (and some real assets) where I thought the decline presented an appealing opportunity - and even with those not buying much. I think you'll - eventually? - have more of a sustained bear market rally but the sort of "what's the next 10x growth story" type conversations are probably over for the foreseeable future and probably expectations going forward (and you saw investor expectations of forward returns rise unrealistically high in 2021, https://twitter.com/SamanthaTwenty/status/1454073210258042890) need to be dialed back for a while. And that's if things don't get materially worse.
ZTS pls. I’m in the field (vet) and they make good products. Looks like they’re jumping more into diagnostics potentially competing with IDXX and also getting into pet insurance with Pumpkin. Having a hard-time wrapping my head around this. Diagnostic market share seems doable, but the pet insurance sector seems thorny with competition. Also can verify the sector is recession-proof….maybe not market crash proof, but definately recession proof. TIA
Straight from fool.com’s premium service Stocks to Buy Today Find your next great stock below, and check back Thursdays for new companies! Thursday, May 12, 2022 Why are these the stocks to buy today? Scroll left/right to view wide tables Company Ticker Price Watchlist Tesla New Stock TSLA $734.00 You own TSLA SolarEdge Technologies SEDG $216.52 Add SEDG to your Watchlist Idexx Laboratories IDXX $333.90 Add IDXX to your Watchlist DexCom DXCM $314.94 Add DXCM to your Watchlist Zoom Video Communications ZM $84.80 Add ZM to your Watchlist Adyen N.V. New Stock ADYE.Y $13.83 Add ADYE.Y to your Watchlist Mastercard MA $325.87 MA is on your Watchlist Arista Networks ANET $102.91 Add ANET to your Watchlist Airbnb, Inc. ABNB $116.15 Add ABNB to your Watchlist Atlassian TEAM $169.28
Down 2.81% for the day but up 1.22% for the month. Tomorrow I’m thinking of focusing on my holdings that are near or at their lowest & invest aggressively there; essentially ignore what’s okay for now. First on my mind is IDXX.
> WOOF Buy IDXX or ZTS not WOOF. Pet health has a considerable moat and is definitely a need. People can buy their pet food anywhere - most grocery stores have a pet food aisle, target has tons of pet food. People have been consolidating trips and WOOF hasn't done well - people can go to TGT and get what they need for themselves and their pet and not have to make a separate stop.
Probably not what you have in mind but I’m looking at IDXX today.
I'm about 50% cash at the moment. Have a couple of long term holds ($CROX, $DBC) and one short position ($CNP). Probably will open a long trade on $IDXX tomorrow - short term swing trade just based on recent price action.
IDXX/ZTS w/animal health. CSGP is a borderline monopoly. CPRT is a business where there's a couple of major players and I think at this point it would be extremely difficult for someone new to come along. WSC is an example of a business where I don't think there's a public peer.
"Maybe on the future, or if their prices hit a bottom, I can invest something like 30% of my portfolio into stocks like Google, Apple, Amazon, and maybe the sceptical Tesla. I just need a starting point." I think it's definitely fine to have exposure to Amazon/Google/etc but I do think that if you're going to get into growth it's a good idea to try to find a couple of best up and coming ideas - really doesn't necessarily have to be something at the very start of its journey, but could be a 25B company where you think that there's a clear path to $100B and perhaps beyond - companies where you think that there's a large potential TAM, great leadership and some degree of optionality (where could this realistically go where it isn't today) and solid moat. Sometimes it's not going to work out, sometimes things initially work out then falter and occasionally you'll find a real gem and maybe you don't find it in the first inning, but if you find it in the third or fourth innning, that's still a pretty potentially great outcome. "What was your process (a quick summary) from finding the stock, to checking the details, to checking the market state? Sorry I ask too much" Not as much in the last year or two, but I would often spend hours and hours searching for new companies. I'll go through 13Fs, screeners and other things, go down the list and then search for companies that I'm not familiar with and quickly decide whether I'm interested or not. I saw one day that a company called Trade Desk had earnings, thought the numbers were impressive, but I think what I thought was particularly interesting was the conference call that followed, where I thought Jeff Green really provided this fantastic combination of industry overview and company fundamentals. I thought this is a person who is excited enough about the industry and opportunity that they could probably talk another couple of hours. The ad tech space has had its share of disasters, but Green had sold his previous ad company to Microsoft and really seemed to have a very clear vision for company. I bought a little - I'm definitely not against tracking positions - and then bought a little more not long after. Citron's short presentation offered another opportunity to buy more. Gradually became a very large position and while there's been some reductions at times, still a large position and added it to it a little bit again this year. In terms of tracking positions, this sounds corny but I do generally view my portfolio sort of in terms of major/minor leagues. Positions often start in A and if they continue to perform, if goals are met, if management continues to deliver, then it's AA, AAA and some become top holdings. Some things never make it past A - and if long enough goes by and they have not, they are often replaced by something else. "My whole finance strategy is basically making sure I am okay with the numbers in my portfolio going up and down." I think a lot of that is personal risk tolerance (and everyone's different) when it comes to investing and really finding investments that you feel very strongly about. If the market is tanking and you look at your portfolio and your first instinct is to hit the sell button, how much confidence did you really have in the first place? So downturns can kind of provide some "truth" if your first instinct is to just to dump a position. "From what I've seen recently, hyper growth stocks seem to have plummeted recently and (reasonably) levelled out." They were absolutely obliterated between around November to March and you've seen a giant bounce in a lot of things in the last couple of weeks or so. Whether that was the bottom or this is a bear market bounce, we don't know - but if this is even moderately sustained I think you might see some of the lower/lowest quality names (no real path to profitability, product not for years, etc) get left behind perhaps somewhat similar to the growth rotation in Feb 2021 where there was a significant rotation and then there was a bounce for the middle of the year - but if you look at a number of things (ARKK, for example) they peaked out in Feb. I think if people are looking through growth after the obliteration a lot of names have had, I do think that people should view things going forward, not anchor to what these names did in 2020/2021; going forward, is the company profitable/is there a clear path to profitability? In 2020, people so badly wanted anything space. I've called SPCE "the world's most expensive theme park ride" with headline risk and other issues. In the $30's, Chamath - who took the company public via SPAC - dumped everything with the excuse of "managing his liquidity." It's now around $10 but got down to $6. I think when there's that growth frenzy, people just have that FOMO where the person who brought it public dumped everything before the first major flight and people still kept asking about it and wondering whether it was going to be big. Management is going to sell some shares sometimes and that's fine, but you have someone who brought something public, promoted it and then exited before the first flight. He didn't believe in it, the stock was a product to be sold and when the growth ducks are quacking they get fed but a lot of it turns out to be junk food. "This is definitely an issue I am worried about. Especially if hyper growth stocks start performing well, I will need to have the knowledge at that point to avoid stocks that have been inflated far too much due to the markets success." Situations can go on for way longer than anyone thinks. For months on end it was "growth stocks only go up." You saw a gradual erosion that started to take down first smaller names, then gradually larger ones. Chegg down 50% in a day, Docusign down 40% in a day, etc. The appetite for growth had exited and all the sudden people were no longer willing to look past earnings that were "just okay" - either growth stocks turned in terrific performance, or they got sold hard. Enough instances of these sort of growth stock annihilations happened and you saw the dumping start to spread because people don't want "my growth stock to be the next Docusign." I thought the rise of growth in 2020 was unsustainable, but I didn't expect the kind of selling that occurred late last year into this year in growth (and you saw "quality but expensive" growth get caught up in that selling, too - DXCM, IDXX. Costco's what, almost 100 points above the Jan low? There's still growth funds down 20%+ for the year. At one point some aggressive growth funds were down 30-35% YTD and it was only March; in 2000-2002 post-dot com I think Janus 20 (the poster child for the period) was down around 67%. ARKK was down 46% or so YTD at one point in March. Do I know that the March low was the low? No idea, but there are points where if you have a long-term view, you start nibbling and around a month or so ago was one of them. I do think again that people have to look at growth going forward with a much tighter filter and focus more on the highest quality ideas. I think the "growthier the growth story the better" period of 2020 was just a period where everything came together for growth. There's a lot of things that I think are not going to see the highs of 2020 for a long time and perhaps in some cases ever. But there's things (not that many) that I think are interesting long-term stories that have gotten totally obliterated.
IDEXX (IDXX) track record of growth during inflation, Amazon Berkshire Hathaway
Hey I appreciate speaking with a fellow well-educated on IDXX stock like yourself because they're hard to find on this subreddit. My responses to your thoughts: - >Zoetis bought abaxis which is interesting and another big player. I did mention I'm a ZTS investor as well. In FY '21, ZTS revenue from Duagnostics was $374m, up 22.6% y/y. IDXX's Companion Animal Group revenue aka Diagnostics was $2,890m, up 21.1%. IDXX is almost 8x larger than ZTS's Diagnostics, but grew at essentially at the same pace over 21% so I'm not worried about competition. I was also a former VCA investor before they got acquired by Mars btw. >Idexx main revenue stream is via selling in-house lab equipment for clinics and hospitals. Actually their main revenue stream is via recurring revenue of consumables & tests to run analyzers to existing customers. The "in-house equipment" formally identified as CAG Diagnostics - Capital was $149m, up 36.9% y/y. $149m/$2,890m means 5% of the revenue segment. Compare the y/y growth to the 6-year straight-line average of 6.3% and that's up because there was pent-up demand for the equipment since the field sales reps had a tough time visiting & selling to offices during the pandemic. Should be a lot easier with a reopened economy now. Also they get equipment into practices via the IDXX 360 program aka get the analyzers for free in return for purchasing x consumables. Not reflected in revenue growth, but reflected in the install base. >Unless there’s is continued growth on the practice owner side i.e new practices opening I feel idexx’s sales will slow. There will be practice growth. This isn't a declining industry with low returns. It's a growing industry with high returns. Also, new practice formation in the past 8 years has added only 1% to IDXX's Companion Animal Revenue growth. What's more important to revenue growth is clinical visit growth, diagnostic frequency (% of visits using diagnostics), and diagnostic utilization (revenue per a clinical visit) >I’d expect them to have less growth over the next 10 years which will likely cause reduction in share price in the long term. I could be wrong but this is my take on it. I don't see less growth. We just had an anecdotal pet adoption boom, spending on pet Healthcare & Diagnostics increases over the life of pets and pets are getting older & living longer. They guided on their investor day to +10% revenue growth for their multi-year goals, which is in-line with their trend since 2016.
Yeah I've been owning them since 2017, half a decade now. I like pet health a lot as you can tell since I've double-dipped with IDXX.
IDXX bought a pharma company back in the day and the price jumped and I sold. I’ve made this mistake a few times that I can remember. Aurellian Gold was another one. I bought at 0.45 and sold at $4.50 in 2006/2007. It then went to $45, was bought out, but I believe on an adjusted basis it went to $200 share. Yes I’ve been investing since 1997. 🏄♂️
>$IDXX at $9 Wow you've been investing since 1995? What interested in you the company at the time when technology for pets isn't where it is today?
The issue becomes - at least often - by the time the thing people have worried about have happened, the opportunities have been missed. There's software names up 20-30%+ in a week or two. Something like IDXX is up 80 straight points. There's a lot of things that have already ramped considerably. Is there going to be more volatility? Sure, absolutely - but imo the time to buy is when people are in the midst of freaking about something and puking their investments, not when the event finally happens.
Have RMD, sure it will do well but one trick ponies are risky, thats why i like IDXX better and 15 other stocks better
I bought DXCM and IDXX, which I haven't owned in a while.
I actually own IDXX again for the first time in a while.
Wigging out over IDXX drop. Stock was inheritance due to death and really hard not to be emotional about the massive bloodbath since the year turned over. Any insights? My gut says hold, but this is has been a rough ride down this time (have had it since 2018).
hard to tell, without a fake pump the daily dip could happen sooner, check IDXX it helps cause it avoids fake dips/pump
my tip, check the daily in yahoo of IDXX it helps to know if it will keep tanking or rallying or better, have 10 charts opened that helps with fake rallies/dips
Bought the dip on IDXX here. Multiple still high but I think the selling is overdone on this one unless ASFV is eradicated in China.
curious, about IDXX. How do you think its going to do in the future with this push in less meat consumption globally, etc
I got a measly 3% return and it's my second year in a row underperforming the stock market (8% last year). What worked well for me this year was animal health stocks including ZTS (49%) and IDXX (34%) What didn't work well is my top stock ROKU (-28%) and my video game stocks including ATVI (-26%) along with TTWO (-12%) and EA (-5%). Another rough year, but I won't be adjusting my portfolio. I'll keep DCA averaging into my biggest lovers and hopefully outperform in 2022.
check ETFs daily price to catch on moves mins early to avoid fake dips, fake rallies, same with IDXX.
I heard him interview the president of $IDXX about 2 years ago, I know a little about the business and bought in at ~$195, it’s $607 today.
I bought IDXX at $5 and sold at $6
> - Do you buy individual stocks? Or do you just invest in mutual/index funds? Yes to both, although a very very significant majority is in individual stocks. "If you buy individual stocks, where do you learn about new stocks?" I sit and go through lists of companies and read a lot - and new thoughts about relevant themes based on something I'm reading might lead me back to something I looked at 6 months ago or more. I prefer devoting more time to researching than being active with investing, although the last 20 months have required being more active than I'd like. "What makes you interested in a stock in the first place?" Relevant, durable (growth is potentially sustainable with long runway/significant opportunity) theme, which doesn't have to be something necessarily "exciting." I bought IDXX in 2016 because I thought people underappreciated the growth in pet ownership and did very well. It's pulled back lately, but bought GNRC a little over a year ago because I thought it was a compelling play on a gradually rising amount of climate-related events, along with some compelling potential with their Enbala purchase for distributed energy resources. I've had holdings in a number of life science companies for a while now because businesses like Danaher are tremendously appealing businesses that are very "printer-and-ink" with a lot of consumables/recurring revenue. There's been some exciting businesses, as well. Bought Trade Desk at $70 because I was so impressed by the CEO and the opportunity. The stock splilt somewhere in the $600's (10 for 1) and is now near $100. I started buying Sea (SE) in early 2020 in the $40's. Sometimes thematic bets haven't worked. This hasn't been a good year for payments and cannabis bets haven't done well, although thankfully the latter was not a large bet. Speaking of that, I think position sizing is important - too many people hear about a theme that sounds exciting and all the sudden it's 20% of their portfolio or something. I like cannabis and still think it's a long-term opportunity but it's not one without issues and the path to legalization continues to be bumpy and it has remained a small allocation. Payments used to be a favorite theme, but has become increasingly overcrowded. "What kind of information do you hope to get from social media sites about investing?" I really like reading about what people are interested in but it's more for enjoyment than anything. "What sources do you trust most?" The company - in terms of researching, I look to the company. I don't really have a lot of interest in analysts and CNBC is pretty awful. Financial media is really about getting clicks and it's about popularity/"Elon just tweeted something!"/etc. There's a lot of great companies in the world that I've heard mentioned rarely/if ever on CNBC. Bloomberg is somewhat better. Financial media is a scoreboard for what's going on in the market, I don't think it's a source for ideas - there's news (marketwatch and SA are good for their news feeds) and then if there's something of note it's a springboard to do your own research.
After having a couple of mutual funds grow steadily over the last 5 years (I'm 33), and earning a major bump in salary, I started a TD Ameritrade account this year to dabble in individual equities. I'm aiming to have a portfolio of about 20 stocks by the end of next year. I'm also really working on not getting too attached to any one stock. I don't invest anything I can't lose, am playing the long game, and have a rather high risk tolerance. My TD account is what I consider my "learning/play" account as I also consistently add to three mutual funds between BlackRock (MDLRX) and Vanguard (VEXPX and VFIAX) as well as maxing out my IRA every year for retirement. The question is this: I currently own only 2 shares of IDXX, and am up quite a bit. I also own and believe in SQ, LMND, PINS and DKNG in the long run, and am tempted to buy more as they all currently dip. I won't have enough money to invest in additional shares of IDXX any time soon at $600 a share, so is it worth selling those 2 shares to have more money to spread across growth stocks that are getting hit?
Hold until retirement: IDXX (pets will probably never speak so the tests help let doctors know what's going on with pets) Hold 5 - 10 years: ZTS until innovation like Gene therapies replaces medication Hold 6 months to 1 year: EA they're taking advantage of some management Tumbles at ATVI and are about to release Battlefield 2042